ARTICLE | Company News
Ingenex other research news
February 27, 1995 8:00 AM UTC
The Menlo Park, Calif., company received a $100,000 Phase I SBIR from the NIH to develop genetic suppressor elements (GSEs) to treat HIV and to identify human genes that may be involved in the disease. ...